Bruce G. Allen Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585 Sell
3
-35
-92% -$7.25K ﹤0.01% 909
2026
Q1
$8.53K Sell
38
-6
-14% -$1.5K 0.01% 509
2025
Q4
$10.6K Hold
44
0.01% 469
2025
Q3
$12K Hold
44
0.01% 454
2025
Q2
$11.4K Sell
44
-7
-14% -$1.67K 0.01% 463
2025
Q1
$11.4K Sell
51
-3
-6% -$700 0.01% 447
2024
Q4
$12.3K Buy
54
+16
+42% +$3.85K 0.01% 450
2024
Q3
$9.28K Hold
38
0.01% 488
2024
Q2
$7.27K Hold
38
0.01% 512
2024
Q1
$7.53K Buy
38
+28
+280% +$5.13K 0.01% 519
2023
Q4
$1.72K Buy
+10
New +$1.54K ﹤0.01% 768

Other funds holding RMD

Bruce G. Allen Investments's RMD Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its ResMed (RMD) stake by 92% in Q2 2026, selling an estimated $7.25K and leaving 3 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Bruce G. Allen Investments first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.3K in Q4 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bruce G. Allen Investments held 3 shares of ResMed worth $585 as of Q2 2026.
  • Bruce G. Allen Investments sold 35 ResMed shares in Q2 2026, an estimated $7.25K.
  • ResMed made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #909 holding.
  • Bruce G. Allen Investments first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's ResMed position peaked at $12.3K in Q4 2024.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.